Population diversity among Bordetella pertussis isolates, United States, 1935-2009

Emerging Infectious Diseases

Volumn 18, Issue 8, 2012, Pages 1248-1255

  Schmidtke, Amber J ^a   Boney, Kathryn O ^a   Martin, Stacey W ^a   Skoff, Tami H ^a   Lucia Tondella, M L ^a   Tatti, Kathleen M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIMBRIA PROTEIN; PERTACTIN; PERTUSSIS VACCINE;

ALLELE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BORDETELLA PERTUSSIS; MICROBIAL DIVERSITY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PERTUSSIS; POLYMERASE CHAIN REACTION; STRAIN IDENTIFICATION; TANDEM REPEAT; UNITED STATES; VARIABLE NUMBER OF TANDEM REPEAT;

ALLELES; ANTIGENS, BACTERIAL; BORDETELLA PERTUSSIS; DISEASE NOTIFICATION; FIMBRIAE PROTEINS; GENETIC VARIATION; HUMANS; MINISATELLITE REPEATS; MULTILOCUS SEQUENCE TYPING; PERTUSSIS TOXIN; PERTUSSIS VACCINE; UNITED STATES; VACCINATION; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH;

EID: 84864443064     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1808.120082     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. Summary of notifiable diseases-United States, 2008. MMWR Morb Mortal Wkly Rep. 2010;57:1-94.
2. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA. 2003;290:2968-75. http://dx.doi.org/10.1001/jama.290.22.2968
3. Tatti KM, Sparks KN, Boney KO, Tondella ML. Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. J Clin Microbiol. 2011;49:4059-66. http://dx.doi.org/10.1128/JCM.00601-11
4. Hardwick TH, Cassiday P, Weyant R, Bisgard K, Sanden G. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999. Emerg Infect Dis. 2002;8:44-9. http://dx.doi.org/10.3201/eid0801.010021
5. Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis. 2000;182:1402-8. http://dx.doi.org/10.1086/315881
6. Schouls LM, van der Heide HG, Vauterin L, Vauterin P, Mooi FR. Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol. 2004;186:5496-505. http://dx.doi.org/10.1128/JB.186.16.5496-5505.2004
7. Litt DJ, Neal SE, Fry NK. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol. 2009;47:680-8. http://dx.doi.org/10.1128/JCM.01838-08
8. Kurniawan J, Maharjan RP, Chan WF, Reeves PR, Sintchenko V, Gilbert GL, et al. Bordetella pertussis clones identified by multilocus variable-number tandem-repeat analysis. Emerg Infect Dis. 2010;16:297-300.
9. Advani A, van der Heide HG, Hallander HO, Mooi FR. Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods. 2009;78:297-301. http://dx.doi.org/10.1016/j.mimet.2009.06.019
10. Schmidtke AJ, Tondella ML, Cassiday PK, Bonkosky MM, Tatti KM. Comparison of three molecular typing methods for typing Bordetella pertussis [abstract]. In: 110th General Meeting of the American Society for Microbiology; May 23-27, 2010; San Diego, CA. Washington (DC): American Society for Microbiology; 2010. Abstract C-2591.
11. Tsang RS, Lau AK, Sill ML, Halperin SA, Van Caeseele P, Jamieson F, et al. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J Clin Microbiol. 2004;42:5364-7. http://dx.doi.org/10.1128/JCM.42.11.5364-5367.2004
12. Hunter PR, Gaston MA. Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity. J Clin Microbiol. 1988;26:2465-6.
13. Grundmann H, Hori S, Tanner G. Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms. J Clin Microbiol. 2001;39:41902. http://dx.doi.org/10.1128/JCM.39.11.4190-4192.2001
14. Mattoo SCJ. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:32682. http://dx.doi.org/10.1128/CMR.18.2.326-382.2005
15. Hinman AR, Orenstein WA, Schuchat A; Centers for Disease Control and Prevention. Vaccine-preventable diseases, immunizations, and MMWR-1961-2011. MMWR Surveill Summ. 2011;60(Suppl 4):49-57.
16. Kallonen T, He Q. Bordetella pertussis strain variation and evolution postvaccination. Expert Rev Vaccines. 2009;8:863-75. http://dx.doi.org/10.1586/erv.09.46
17. Maharjan RP, Gu C, Reeves PR, Sintchenko V, Gilbert GL, Lan R. Genome-wide analysis of single nucleotide polymorphisms in Bordetella pertussis using comparative genomic sequencing. Res Microbiol. 2008;159:602-8. http://dx.doi.org/10.1016/j.resmic.2008.08.004
18. Bart MJ, van Gent M, van der Heide HG, Boekhorst J, Hermans P, Parkhill J, et al. Comparative genomics of prevaccination and modern Bordetella pertussis strains. BMC Genomics. 2010;11:627. http://dx.doi.org/10.1186/1471-2164-11-627
19. Komatsu E, Yamaguchi F, Abe A, Weiss AA, Watanabe M. Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model. Clin Vaccine Immunol. 2010;17:807-12. http://dx.doi.org/10.1128/CVI.00449-09
20. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis. 2009;15:1206-13. http://dx.doi.org/10.3201/eid1508.081511
21. King AJ, Berbers G, van Oirschot HF, Hoogerhout P, Knipping K, Mooi FR. Role of the polymorphic region 1 of the Bordetella pertussis protein pertactin in immunity. Microbiology. 2001;147:2885-95.
22. He Q, Makinen J, Berbers G, Mooi FR, Viljanen MK, Arvilommi H, et al. Bordetella pertussis protein pertactin induces type-specific antibodies: one possible explanation for the emergence of antigenic variants? J Infect Dis. 2003;187:1200-5. http://dx.doi.org/10.1086/368412
23. Mooi FR, Hallander H, Wirsing von Konig CH, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis. 2000;19:174-81. http://dx.doi.org/10.1007/s100960050455
24. Kodama A, Kamachi K, Horiuchi Y, Konda T, Arakawa Y. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J Clin Microbiol. 2004;42:5453-7. http://dx.doi.org/10.1128/JCM.42.12.5453-5457.2004
25. Hausman SZ, Burns DL. Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization. Infect Immun. 2000;68:3763-7. http://dx.doi.org/10.1128/IAI.68.6.37633767.2000
26. Williamson P, Matthews R. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. FEMS Immunol Med Microbiol. 1996;13:169-78.
27. Mouillot D, Lepretre A. A comparison of species diversity estimators. Res Popul Ecol (Kyoto). 1999;41:203-15.